Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +33.64%
#3 Cysic Cysic +24.17%
#4 Nockchain Nockchain +18.65%
#5 Velvet Velvet +18.00%
#6 Nillion Nillion +13.02%
#7 FOLKS FOLKS +12.57%
#8 Versatize Coin Versatize Coin +12.49%
#9 Humanity Humanity +11.40%
#10 Bedrock Bedrock +10.87%
Coin of the day
EXOD EXOD
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Medesis Pharma S.A. Medesis Pharma S.A.

Medesis Pharma S.A.

ALMDP
Rang în acțiuni #37493
Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development... Medesis Pharma S.A. is a biopharmaceutical firm in the clinical development phase, dedicated to creating orally delivered molecular drug therapies aimed at critical medical conditions lacking effective treatments. The company's pipeline features several innovative compounds, including NanoLithium (NP03), which is currently undergoing clinical trials for Alzheimer's disease, and NanosiRNA DH, targeting Huntington's Disease. Medesis Pharma also develops NU01 Plutonium and NU02 Cesium for nuclear decorporation, alongside NP02 – NanoManganese, a radioprotection medication designed for individuals exposed to radiation from nuclear incidents. Furthermore, their portfolio encompasses NanosiRNA COVID-19, an antiviral solution for various viral infections, and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for oncological applications. Established in 2003, the enterprise operates from its headquarters in Montpellier, France.
Preț acțiune
$0.38207938
Ultima sincronizare: 2025-04-07
Capitalizare de piață
$1.67M
Schimbare (1 zi)
-0.39%
Schimbare (1 an)
0.00%
Țară
FR
Tranzacționează Medesis Pharma S.A. (ALMDP)

Categorie

Healthcare
Raport P/S pentru Medesis Pharma S.A. (ALMDP)
Raport P/S la data de 2026 TTM: 0
Conform celor mai recente rapoarte financiare și prețului acțiunilor Medesis Pharma S.A., raportul P/S actual (TTM) este 0. La sfârșitul anului 2026, compania avea un P/S de 0.
Istoricul raportului P/S pentru Medesis Pharma S.A. din 2026 până în 2026
Raport P/S la sfârșitul fiecărui an
An Raport P/S Schimbă
Nu sunt suficiente date pentru perioada selectată.
Raport P/S pentru companii similare sau competitoare
Companie Raport P/S Diferență raport P/S Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE